A
Real Estate

Alexander's, Inc.

ALX
Since

Headquarters:

NJ, United States

Exchange:

NYSE

Industry:

REIT—Retail

Number of Employees:

92.00

Current Fiscal Year:

2025

Market Cap:

1.07B

Price per Share:

$208.72

Quarterly Dividend per Share:

$4.50
Year-to-date Performance:
6.3704%
Dividend Yield:
8.67%
Price-to-book Ratio:
6.03
Trailing P/E Ratio:
24.54

Price History

Latest Prices

DateOpenHighLowClose
2025-05-01206.0713211.01206.0713208.72
2025-04-30203.5487208.1735203.495206.4
2025-04-29205.36206203.4205.5
2025-04-28207.65207.65207.01207.01
2025-04-25201201198.57200.61

Alexander's, Inc. (NYSE: ALX) is a real estate investment trust (“REIT”), incorporated in Delaware, engaged in leasing, managing, developing and redeveloping its properties. All references to “we,” “us,” “our,” “Company” and “Alexander's” refer to Alexander's, Inc. and its consolidated subsidiaries. We are managed by, and our properties are leased and developed by, Vornado Realty Trust (“Vornado”) (NYSE: VNO). We have five properties in New York City.

Financial Performance

2025 Revenue:226.37M

Detailed view of quarterly revenue

2025 Net Income:43.44M

Detailed view of quarterly net income

2025 Free Cash Flow:54.11M

Overview of free cash flow for the quarter

Annual Revenue Comparison

Compares total annual revenues

Similar Companies

Real Estate
ARE
Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria has a total market capitalization of $34.4 billion and an asset base in North America of 74.1 million SF as of March 31, 2024, which includes 42.2 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years, 2.5 million RSF of priority anticipated development and redevelopment projects, and 24.1 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
12.83B
Market Cap
*Data based on the last 12 months.